new study showing coenzyme Q10 might slow progression of Parkinson's disease
November 2002
Patients are asking about the new study showing coenzyme Q10 might slow progression of Parkinson's disease.
Researchers suspect that coenzyme Q10 improves energy production in the mitochondria. Parkinson's patients seem to have lower levels of CoQ10 and reduced mitochondrial function.
CoQ10 is also a potent antioxidant that might protect brain cells.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote